Q32 Bio Inc. (QTTB) Preferred Stock Liabilities (2017 - 2023)

Q32 Bio has reported Preferred Stock Liabilities for 3 years, with the latest figure at $111.4 million in Q4 2023.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $111.4 million in Q4 2023; TTM through Dec 2023 was $111.4 million, a N/A change from a year earlier, with the FY2023 full-year figure at $111.4 million, changed N/A from the prior year.
• Preferred Stock Liabilities was $111.4 million for Q4 2023 at Q32 Bio, down from $137.8 million in the prior quarter.
• The five-year high for Preferred Stock Liabilities was $111.4 million in Q4 2023, with the low at $111.4 million in Q4 2023.